WayPoint Biomedical Holdings, Inc.
WYPH
$0.0001
$0.000.00%
| 06/30/2006 | 03/31/2006 | ||||
|---|---|---|---|---|---|
| Revenue | -71.15% | -70.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -71.15% | -70.45% | |||
| Cost of Revenue | -97.70% | -59.53% | |||
| Gross Profit | 137.14% | 7.89% | |||
| SG&A Expenses | 41.83% | -13.18% | |||
| Depreciation & Amortization | 22.22% | -- | |||
| Other Operating Expenses | -- | -0.97% | |||
| Total Operating Expenses | 39.85% | -16.54% | |||
| Operating Income | -42.87% | 12.02% | |||
| Income Before Tax | -30.80% | -2.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.66% | -2.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.66% | -2.26% | |||
| EBIT | -42.87% | 12.02% | |||
| EBITDA | -43.35% | 12.24% | |||
| EPS Basic | 28.17% | 1.39% | |||
| Normalized Basic EPS | -9.09% | 2.22% | |||
| EPS Diluted | 28.17% | 1.39% | |||
| Normalized Diluted EPS | -9.09% | 2.22% | |||
| Average Basic Shares Outstanding | 21.42% | 2.86% | |||
| Average Diluted Shares Outstanding | 21.42% | 2.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
